Brass Tax Wealth Management Inc. purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 600 shares of the biotechnology company’s stock, valued at approximately $240,000.
Other institutional investors also recently modified their holdings of the company. Public Sector Pension Investment Board increased its holdings in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares in the last quarter. CIBC Asset Management Inc raised its stake in Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the period. Foundations Investment Advisors LLC acquired a new stake in Axon Enterprise during the 3rd quarter valued at $221,000. Sequoia Financial Advisors LLC raised its stake in Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after purchasing an additional 81 shares during the period. Finally, Axxcess Wealth Management LLC acquired a new stake in Axon Enterprise during the 3rd quarter valued at $814,000. Institutional investors own 79.08% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the stock. JMP Securities boosted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Northland Securities boosted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird boosted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $488.67.
Axon Enterprise Stock Up 0.4 %
NASDAQ:AXON traded up $2.54 during trading hours on Friday, reaching $638.95. The company’s stock had a trading volume of 133,072 shares, compared to its average volume of 570,881. The company has a market cap of $48.72 billion, a price-to-earnings ratio of 164.45, a price-to-earnings-growth ratio of 14.14 and a beta of 1.01. Axon Enterprise, Inc. has a one year low of $241.72 and a one year high of $698.67. The business’s 50-day moving average is $535.05 and its 200-day moving average is $402.14. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.
Insider Buying and Selling
In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeri Williams sold 110 shares of the company’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the sale, the director now owns 1,934 shares of the company’s stock, valued at $773,600. This trade represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 99,590 shares of company stock worth $49,176,907. Corporate insiders own 6.10% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Consumer Discretionary Stocks Ready for a Comeback in 2025
- Conference Calls and Individual Investors
- Top 3 Robotics and Automation Stocks for the Next AI Boom
- Canadian Penny Stocks: Can They Make You Rich?
- Why a Stock Split Could Be a Game-Changer for Casey’s in 2025
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.